Fulvestrant
Fulvestrant is a synthetic estrogen receptor antagonist used alone or in combination with another medicine to treat certain types of breast cancer.
Generic marketed in US since 2019
Therapeutic group
Endocrine therapy, anti-estrogens
ATC code: L02BA03
Generic marketed in US since 2019
Therapeutic group
Endocrine therapy, anti-estrogens
ATC code: L02BA03
Fulvestrant
Key dosage forms
- Solution for intramuscular injection (50 mg/mL)
Features
- Strong support from reliable partner
- Cost-effective newly developed process
Some brand names
- FASLODEX® (ASTRAZENECA)